Chunxia Du
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Vascular Tumors and Angiosarcomas
-
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
- Brain Metastases and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Gastric Cancer Management and Outcomes 5
- Oncology 7
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 2
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Jinwan Wang (5 shared papers)Yongkun Sun (4 shared papers)Yihebali Chi (3 shared papers)Feng Du (1 shared paper)Li Li (2 shared papers)Wei Niu (2 shared papers)Feng‐Qing Wang (1 shared paper)Shuting Li (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Hematology & Oncology (1 paper)Molecular Carcinogenesis (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Journal of Neuro-Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chunxia Du
18 papers receiving 424 citations
Chunxia Du's Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 220
- Pulmonary and Respiratory Medicine 132
- Cancer Research 34
- Endocrinology, Diabetes and Metabolism 19
- Gastroenterology 6
Countries citing papers authored by Chunxia Du
This map shows the geographic impact of Chunxia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Du more than expected).
Fields of papers citing papers by Chunxia Du
This network shows the impact of papers produced by Chunxia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Du. The network helps show where Chunxia Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Chunxia Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors Hit paper breakdown → | 2016 | 337 |
| 2 | 2013 | 20 | |
| 3 | 2013 | 19 | |
| 4 | 2024 | 11 | |
| 5 | 2016 | 11 | |
| 6 | 2013 | 7 | |
| 7 | 2022 | 6 | |
| 8 | 2024 | 4 | |
| 9 | 2015 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2009 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2020 | 1 | |
| 16 | [Analysis of the prognosis of 111 patients with gastric cancer or adenocarcinoma of the esophagogastric junction combined with pleural or abdominal effusion]. | 2013 | 1 |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Chunxia Du
Chunxia Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 21 papers that have together received 429 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Multiple and Secondary Primary Cancers (1 paper), DNA Repair Mechanisms (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (220 citations), Pulmonary and Respiratory Medicine (132 citations), Cancer Research (34 citations), Endocrinology, Diabetes and Metabolism (19 citations) and Gastroenterology (6 citations). Chunxia Du has collaborated with scholars based in China and United States. Frequent co-authors include Jinwan Wang, Yongkun Sun, Yihebali Chi, Feng Du, Li Li, Wei Niu, Feng‐Qing Wang, Shuting Li, Hao Yu and Chuan Li. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hematology & Oncology, Molecular Carcinogenesis, The Journal of Clinical Endocrinology & Metabolism and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.